Last year, we reported an adjusted net loss of $12,000,000 or $0.10 per share for the Q3 of 2022. That included $11,000,000 or $0.09 per share of investment loss from alternative investments and $11,000,000 or $0.09 per share of other net expense items. Alternative investments, investment income based on management's long term expected Return of approximately 10% was $106,000,000 or $0.85 per share. For comparison, adjusting for these significant items in both Period, adjusted net earnings were $148,000,000 up 28% from $116,000,000 in the Q3 of 2022 And adjusted return on assets was 119 basis points as compared to 111 basis points in the prior year quarter. This $32,000,000 increase in adjusted net earnings and 8 basis points increase in ROA was generated by $56,000,000 or 24 basis from higher product margin over the prior year driven by asset growth, floating rate asset uplift and disciplined pricing and $14,000,000 or 7 basis points increase from accretive flow reinsurance, which includes expense allowance reimbursement, partially offset by $34,000,000 or 21 basis points decrease from higher expenses related to higher interest expense In line with our capital markets activity and higher operating costs, in line with our growth in sales and assets and continued investments in our operating platform and $4,000,000 or 2 basis points decrease from our annual actuarial assumption updates and other.